Pharmaceutical Preparations · DE · CIK 34956
Develops cardiovascular and pulmonary disease therapeutics, prioritizing pulmonary hypertension treatments like Levosimendan
Comparable business profile · signals at a glance
In the 90 days to Dec 9, 2025: 4 insiders bought $205K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 9, 2025 | Rich StuartChief Medical Officer | Buy | 2,500 | $10.22 | $26K |
| Dec 8, 2025 | Rich StuartChief Medical Officer | Buy | 2,500 | $10.10 | $25K |
| Dec 4, 2025 | Rich StuartChief Medical Officer | Buy | 2,500 | $9.20 | $23K |
| Dec 3, 2025 | Rich StuartChief Medical Officer | Buy | 1,500 | $9.08 | $14K |
| Dec 2, 2025 | Rich StuartChief Medical Officer | Buy | 1,000 | $9.01 | $9K |
| Nov 20, 2025 | Giordano Christopher ThomasCEO | Buy | 538 | $7.59 | $4K |
| Nov 19, 2025 | Giordano Christopher ThomasCEO | Buy | 455 | $7.51 | $3K |
| Nov 18, 2025 | Almenoff June SherieDirector | Buy | 1,900 | $7.52 | $14K |
| Nov 18, 2025 | Almenoff June SherieDirector | Buy | 1,900 | $7.52 | $14K |
| Nov 18, 2025 | Giordano Christopher ThomasCEO | Buy | 1,612 | $7.75 | $12K |
| Nov 17, 2025 | Mcgauley ThomasInterim CFO | Buy | 5,000 | $7.23 | $36K |
| Nov 17, 2025 | Mcgauley ThomasInterim CFO | Buy | 2,000 | $7.34 | $15K |
| Nov 17, 2025 | Mcgauley ThomasInterim CFO | Buy | 1,000 | $7.35 | $7K |
| Nov 17, 2025 | Almenoff June SherieDirector | Buy | 93 | $7.15 | $665 |
| Nov 17, 2025 | Almenoff June SherieDirector | Buy | 93 | $7.15 | $665 |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.